Tailored Mediterranean Lifestyle Education in Patients With Mild Cognitive Impairment

November 1, 2019 updated by: Jayne Woodside, PhD, Queen's University, Belfast

The Development and Pilot Testing of Tailored Mediterranean Lifestyle Education to Encourage Behaviour Change in Patients With Mild Cognitive Impairment

Evidence suggests that a Mediterranean diet can have a beneficial effect on brain health. Mild cognitive impairment (MCI) describes problems with brain function such as difficulty with day-to-day memory and concentration. It is at this stage that Mediterranean diet could prove beneficial in terms of prevention.

Previous research by Queens University investigated the opinions of patients with MCI and their care givers to inform the development of Mediterranean diet education material to encourage behaviour change. The study suggested that MCI patients lacked awareness of the link between Mediterranean diet and brain function, although were interested to learn more. Feedback on the developed educational material was positive although there were suggested improvements such as tailoring information to memory loss, a potential staged approach to delivery and adaptations to the material content.

This present study aims to pilot test refined educational material among MCI participants to evaluate the feasibility of encouraging dietary behaviour change among this patient group.

Study Overview

Detailed Description

This study aims to evaluate the feasibility of a theory-based, tailored Mediterranean lifestyle education intervention to encourage behaviour change in patients with MCI. The proposed study will be a 6 month RCT with a total of 60 MCI patients who will be randomised to 1 of 3 groups:

  1. Group 1 will receive the Mediterranean lifestyle education resource on one occasion at baseline
  2. Group 2 will receive the Mediterranean lifestyle education resource at monthly intervals for 5 months accompanied by telephone feedback from the research dietitian
  3. Group 3 will receive standard care (control group). Participants will receive the Mediterranean lifestyle education resource after their final 6 month study visit (i.e. delayed intervention).

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Belfast, United Kingdom, BT9 7AB
        • Belfast Health and Social Care Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria

  • Diagnosis of Mild Cognitive Impairment by their physician
  • Mediterranean diet score (MDS) less than or equal to 4 (Estruch et al., 2006)
  • Willing to make changes to their diet

Exclusion Criteria:

  • Diagnosis of dementia
  • Patients with visual or English language impairment
  • Psychiatric problems
  • Significant medical comorbidity
  • Body Mass Index (BMI) ≤ 19 and ≥ 40 kg/m2
  • Excessive alcohol consumption
  • Taking high dose nutritional supplements
  • Dietary restrictions/allergies that would substantially limit ability to complete study requirements
  • Inability to provide informed consent
  • History of, or comorbid condition which may alter performance on cognitive tests e.g. stroke, head injury, Parkinson's disease, learning disability

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group 1: "ThinkMed" resource at baseline
The "ThinkMed" resource contains an information booklet, recipe books, menu plan cards, shopping list cards and goal setting cards. Participants will receive this resource on one occasion at baseline (n=20)
The "ThinkMed" resource contains an information booklet, recipe books, menu plan cards, shopping list cards and goal setting cards. Participants will receive this resource on one occasion at baseline.
Experimental: Group 2: "ThinkMed" resource (staged)
This group of participants will receive the "ThinkMed" resource at monthly intervals for 5 months accompanied by telephone feedback from the research dietitian (n=20)
This group of participants will receive the "ThinkMed" resource at monthly intervals for 5 months accompanied by telephone feedback from the research dietitian
Placebo Comparator: Group 3: Standard Care (control) group
Participants will continue with the standard care provided by their physician. Participants will receive the "ThinkMed" resource after their final 6 month study visit (i.e. delayed intervention) (n=20)
Participants will continue with the standard care provided by their physician. Participants will receive the "ThinkMed" resource after their final 6 month study visit (i.e. delayed intervention).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Mediterranean Diet Score (MDS) at 6 months
Time Frame: Baseline, 6 months
Mediterranean dietary intake will be measured by a validated questionnaire
Baseline, 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical Activity
Time Frame: Baseline, 6 months
RPAQ-Recent Physical Activity Questionnaire
Baseline, 6 months
Anthropometric measurements
Time Frame: Baseline, 6 months
Weight and height measurements to calculate BMI
Baseline, 6 months
Muscle Strength
Time Frame: Baseline, 6 months
Measured using a grip-strength dynamometer
Baseline, 6 months
Geriatric Depression Scale
Time Frame: Baseline, 6 months
Geriatric Depression Scale Questionnaire
Baseline, 6 months
Functional Assessment (1)
Time Frame: Baseline, 6 months
Measured by the instrumental activities of daily living scale (IADL) by Lawton and Brody (1969) questionnaire
Baseline, 6 months
Cognitive Assessment
Time Frame: Baseline, 6 months
A comprehensive cognitive assessment will be performed, including: global cognition, motor skills, executive function episodic/visual memory, and information processing and sustained attention using a validated neuropsychological test battery (Cantab Cognitive Battery, Cambridge Cognition Ltd.)
Baseline, 6 months
Barriers to consuming a Mediterranean Diet questionnaire
Time Frame: Baseline, 6 months
Dietary behaviour change questionnaire to measure adherence to a Mediterranean diet
Baseline, 6 months
Blood Sample
Time Frame: Baseline, 6 months
A blood sample will be taken from participants to be stored for analysis of biomarkers of MD adherence and biomarkers of neurodegenerative disease risk.
Baseline, 6 months
Functional Assessment (2)
Time Frame: Baseline, 6 months
Measured by the Bristol activities of daily living scale (Bucks et al. 1996) questionnaire
Baseline, 6 months
4-day Food Diary
Time Frame: Baseline, 6 months
A food diary will be completed to assess compliance with a Mediterranean diet
Baseline, 6 months
Change in Lifestyle questionnaire
Time Frame: Baseline, 6 months
A questionnaire to measure change in lifestyle behaviours
Baseline, 6 months
Dietary Quality of Life questionnaire
Time Frame: Baseline, 6 months
A questionnaire to measure dietary quality of life
Baseline, 6 months
Mediterranean Diet Knowledge questionnaire
Time Frame: Baseline, 6 months
A questionnaire to measure participants Mediterranean diet knowledge
Baseline, 6 months
Rand SF-36 HEALTH SURVEY
Time Frame: Baseline, 6 months
A questionnaire to measure participants views and beliefs on health
Baseline, 6 months
Staging Algorithm Questionnaire
Time Frame: Baseline, 6 months
A questionnaire to measure participants readiness to change their diet and lifestyle
Baseline, 6 months
Mediterranean Diet self-efficacy questionnaire
Time Frame: Baseline, 6 months
A questionnaire to measure participants self-efficacy
Baseline, 6 months
Mediterranean diet tolerance questionnaire
Time Frame: Baseline, 6 months
A questionnaire to measure tolerance to a Mediterranean diet
Baseline, 6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Process Evaluation (1) - telephone contact evaluation
Time Frame: up to 3 months post intervention
Determination individual participation and engagement with the intervention by reviewing telephone contact log record and telephone checklist evaluation
up to 3 months post intervention
Process Evaluation (2) - study records
Time Frame: up to 3 months post intervention
A review of study records- including attrition rates, reason for dropout
up to 3 months post intervention
Process Evaluation (3) - structured interviews
Time Frame: up to 3 months post intervention
Post intervention structured interviews for participant evaluation of the intervention programme and dietary educational materials
up to 3 months post intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Jayne Woodside, PhD, Queens University Belfast

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2017

Primary Completion (Actual)

June 30, 2019

Study Completion (Actual)

June 30, 2019

Study Registration Dates

First Submitted

August 23, 2017

First Submitted That Met QC Criteria

August 25, 2017

First Posted (Actual)

August 29, 2017

Study Record Updates

Last Update Posted (Actual)

November 4, 2019

Last Update Submitted That Met QC Criteria

November 1, 2019

Last Verified

November 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 16/NI/0105

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mild Cognitive Impairment

Clinical Trials on "ThinkMed" resource at baseline

3
Subscribe